Navigation Links
Life Sciences Leaders to Launch Statewide 'We Work for Health' Economic Development and Jobs Campaign
Date:4/20/2009

Group to Release Groundbreaking Study on Economic Impact of Life Sciences Sector on Washington State

SEATTLE, April 20 /PRNewswire/ -- An alliance of Washington state business, academic, government and community leaders will launch "We Work for Health," a landmark statewide effort to enhance the public's understanding of the economic impact of Washington's life sciences industry and to promote the growth and success of the sector.

We Work for Health will release the results of a groundbreaking study demonstrating the economic impact of the life sciences and biopharmaceutical sector in Washington state. The study will highlight the number of jobs created directly and indirectly by the biotechnology, biopharmaceutical, biomedical and research companies that make Washington an international hub for life sciences innovation.

WHAT

News conference to launch We Work for Health, a statewide economic development and jobs advocacy coalition.

Release of job creation and economic impact study by Archstone Consulting of biopharmaceutical and related industries in Washington state.

Tour of Seattle Children's Research Institute to illustrate importance of life sciences jobs in Washington state.

    WHEN
    Thursday, April 23, 2009
    10 a.m. News Conference
    10:45 a.m. Tour of Seattle Children's Research Institute with President James B. Hendricks, PhD.

    WHERE
    Seattle Children's Research Institute
    Soundgarden Room, 11th floor
    1900 9th Ave.
    Seattle, WA 98101

Complimentary parking is available in the Diamond Parking garage in the Children's building. The entrance is located in the alley off Stewart Street between 9th and Terry.

WHO

We Work for Health Co-Chairs

  • Bob Drewel, Executive Director, Puget Sound Regional Council
  • Dr. Elson S. Floyd, President, Washington State University
  • Dr. Lee Huntsman, Executive Director, Life Sciences Discovery Fund
  • Chris Rivera, President, Washington Biotechnology and Biomedical Association
  • Rogers Weed, Director of the Washington State Department of Community, Trade and Economic Development

Presenter

Michael Eckstut, Life Sciences Practice Leader, Archstone Consulting

BACKGROUND

We Work for Health is a statewide effort uniting organizations, companies, individuals and other stakeholders around a common goal: to educate policymakers and key opinion leaders about the economic impact of the life sciences innovation pipeline and to promote and grow the industry in Washington state. We Work for Health seeks to raise awareness of the impact of public policy on innovation in the life sciences, related industries and surrounding communities.

Media Contacts: Chelsea Waliser or Nate Cole-Daum, Nyhus Communications LLC for We Work for Health, (206) 323-3733 | chelsea@nyhus.com or nate@nyhus.com


'/>"/>
SOURCE We Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caliper Life Sciences First Quarter 2009 Financial Results Conference Call Notice
2. Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson
3. HBO, UCSD Shiley-Marcos Alzheimers Disease Research Center, The Alzheimers Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMERS PROJECT: MOMENTUM IN SCIENCE
4. Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board
5. Advanced Life Sciences Announces Results of Shareholder Meeting and Provides Additional Information on Upcoming Advisory Committee Meeting
6. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
7. Derma Sciences Reports Fourth Quarter, Year-End Results for 2008
8. Human Pheromone Sciences Announces Fourth Quarter and Full Year Results
9. ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.
10. Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
11. Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology: